Loading company…
Pharmasset is a Princeton biopharmaceutical company focused on antiviral medicines for hepatitis C and HIV.
Founded in 1998 in Princeton, US, Pharmasset, Inc. develops antiviral medicines, particularly for hepatitis C and HIV. Gilead Sciences, Inc. acquired the company in January 2012 for USD 11.2 billion, after an IPO in April 2007. In 2011 it generated revenue of USD 897,000 and EBITDA of USD -91,006,000.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in